Results 151 to 160 of about 87,437 (368)

Brentuximab vedotin as monotherapy or combination therapy for cutaneous peripheral T cell lymphoma – a retrospective study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Cutaneous peripheral T cell lymphomas (PTCL) are rare and show an aggressive course with limited response to therapy. The efficacy of brentuximab vedotin in cutaneous peripheral T cell lymphomas has not yet been systematically investigated.
Caroline Glatzel, Inga Hansen‐Abeck, Nina Booken, Johannes Düll, Matthias Goebeler, Patrick Schummer, Marion Wobser   +6 more
wiley   +1 more source

Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia [PDF]

, 1992
Wiernik Ph, PL Banks, DC Jr Case, Arlin Za, PO Periman, MB Todd, PS Ritch, RE Enck, AB Weitberg   +8 more
openalex   +1 more source

Enhanced Antitumor Efficacy of Cytarabine and Idarubicin in Acute Myeloid Leukemia Using Liposomal Formulation: In Vitro and In Vivo Studies

Pharmaceutics
Background: Acute myeloid leukemia (AML) is the most common type of acute leukemia among adults with the recommend therapy of combination of cytarabine and idarubicin in the induction phase.
Chunxia Zhu, Yang Liu, Xiaojun Ji, Yaxuan Si, Xianhao Tao, Xiaohua Zhang, Lifang Yin   +6 more
doaj   +1 more source

Fused-core HPLC method development implemented in a short-term stability study of Triple IT solution [PDF]

, 2011
For the majority of children with acute lymphoblastic leukemia (ALL), treatment consists in part of a triple intrathecal (Triple IT) therapy, i.e. a combination of cytarabine (CB), methotrexate (MTX) and methylprednisolone sodium succinate (MPSS) [1 ...
Bauters, Tieneke, D'Hondt, Matthias, De Spiegeleer, Bart, Lemeire, Nadia, PELFRENE, BRIGITTE, Robays, Hugo, Vandenbroucke, Johan, Vangheluwe, Elien   +7 more
core  

The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study [PDF]

, 1993
K B Miller, K. Kyungmann, Francis S. Morrison, Jane N. Winter, John M. Bennett, Richard S. Neiman, David R. Head, Peter A. Cassileth, M J O'Connell   +8 more
openalex   +1 more source

Tandem combination of ASCT and CAR T‐cell therapy in highly refractory CNS lymphomas

British Journal of Haematology, EarlyView.
Lydia Montes, Sylvain Choquet, Madalina Uzunov, Véronique Morel, Marine Baron, Damien Roos‐Weil, Magalie Joris, Caroline Delette, Delphine Lebon, Nabih Azar, Carole Metz, Lucia Nichelli, Magali Le Garff‐Tavernier, Clémentine Boccon‐Gibod, Claire Lacan, Laetitia Souchet, Khê Hoang‐Xuan, Carole Soussain, Inès Boussen, Caroline Houillier   +19 more
wiley   +1 more source

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

European Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

Neutropenic enterocolitis in hemato-oncological patients [PDF]

, 2015
Background Neutropenic enterocolitis (NE) is a life-threatening complication in patients undergoing intensive chemotherapy for hematological malignancies.
SANTOS, G.
core  

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia [PDF]

, 1992
Gary J. Schiller, James Gajewski, Mary Territo, S D Nimer, Myung Lee, T Belin, R Champlin   +6 more
openalex   +1 more source

Pharmacovigilance‐Based Identification and Mechanistic Exploration of Periodontitis‐Related Drugs

Journal of Clinical Periodontology, EarlyView.
ABSTRACT Background Periodontitis is a common chronic inflammatory disease. However, drug‐related risks and underlying molecular mechanisms remain underexplored from large real‐world data. Methods We first mined the US Food and Drug Administration Adverse Event Reporting System (FAERS) database to identify drugs disproportionately associated with ...
Wuda Huoshen, Junkai Xiong, Xunmi Ma, Heng Wang, Panyu Cheng, Xinyu Chen, Ge Shuai, Yi Chen, Xinyue Zhang, Chen Sun, Chunhui Li, Rui Shi   +11 more
wiley   +1 more source